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background: It has been postulated that the availability of a transcatheter aortic valve replacement (TAVR) program would also increase the 
number of patients treated with surgical AVR (SAVR), but this has not been well analyzed.
Methods: Data from a regional quality initiative of 27 hospitals (3 with TAVR programs) in a large US metropolitan area from 2008-2012 was 
analyzed. The number of SAVR and TAVR procedures at hospitals with and without a TAVR program were compared. The impact of TAVR on patient 
selection for SAVR as measured by the Society of Thoracic Surgeons (STS) predicted risk of mortality (PROM) risk algorithm was also evaluated.
results: Overall, the number of patients with AS treated increased from 604 to 854, a 44% (11% per annum) increase, so that by 2012, 188/874 
(21.5%) were performed by TAVR. The number of SAVR cases increased until 2010, when they began declining at both types of centers. (Figure) STS 
PROM for SAVR patients was lower at non-TAVR versus TAVR hospitals (3.62 ± 4.10; median 2.48 versus 4.68 ± 4.79; median 3.09, p < 0.001). The 
mean PROM at non-TAVR hospitals ranged from 3.3 to 3.7 while at TAVR hospitals the values ranged from 4.3 to to 5.1, but has dropped to 3.9 in 
2012.
conclusions: In this large metropolitan area, there was initially a small increase in SAVR volume at both hospitals with and without TAVR programs, 
with declining volume since 2010. The majority of increase in aortic valve procedures performed was due to TAVR with a shift toward higher risk 
patients being treated with TAVR.
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